Form 4: Atai Beckley Director Granted Stock Options

Sentiment:

Insider Transaction Report


Atai Beckley N.V. Director Scott Braunstein was granted 56,818 stock options with an exercise price of $5.28, vesting fully on November 4, 2026.

Summary

  • Scott Braunstein, a Director of Atai Beckley N.V. (ATAI), was granted stock options on November 4, 2025.
  • A total of 56,818 derivative securities (stock options) were acquired.
  • The exercise price for these options is $5.28 per share.
  • The options will vest 100% on the first anniversary of the grant date, which is November 4, 2026.
  • The expiration date for these options is November 4, 2035.
  • Following this transaction, Scott Braunstein beneficially owns 56,818 derivative securities directly.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a routine compensation event that aligns the director's interests with shareholders, which is generally viewed as a positive for corporate governance and long-term performance incentives.

Positives

  • The grant of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.
  • The options have a 10-year expiration period, providing a long-term incentive for the director.

Negatives

  • Potential future dilution for existing shareholders if the options are exercised, although this is a standard aspect of equity compensation.

Risks

  • No specific risks are detailed in this Form 4 filing beyond the inherent risks associated with equity compensation, such as potential future share dilution.

Future Outlook

The stock options are scheduled to vest 100% on November 4, 2026, which is the first anniversary of the grant date. The options will expire on November 4, 2035.

Industry Context

Granting stock options to directors is a common practice in publicly traded companies, particularly in sectors like biotechnology and pharmaceuticals where long-term development cycles necessitate long-term incentives. This practice aims to align the interests of directors with those of shareholders by tying compensation to the company's stock performance.

Comparison to Industry Standards

  • The grant of stock options to a director is a standard form of equity compensation within the industry.
  • The vesting schedule (100% on the first anniversary) and the 10-year expiration period are typical for such grants in comparable companies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation StructureThe grant of stock options to a director is a standard component of corporate governance related to executive and director compensation, designed to align interests. No changes to bylaws or policies are explicitly mentioned.11/04/2025Enhances alignment between director incentives and long-term shareholder value.

Related Party Transactions

  • The grant of stock options to Scott Braunstein, a Director, constitutes a related party transaction as it involves compensation provided by the company to an insider.

Stakeholder Impact

  • Shareholders: Potential for future dilution if options are exercised, but also benefit from improved alignment of director incentives with long-term company value creation.

Next Steps

  • The stock options will vest on November 4, 2026.
  • The director may choose to exercise the options at any time after vesting and before the expiration date of November 4, 2035, assuming the stock price is above the exercise price.

Key Dates

DateDescription
11/04/2025Transaction Date (Grant Date of Stock Option)
11/06/2025Signature Date of Reporting Person's attorney-in-fact
11/04/2026Date Exercisable (First anniversary of grant date, when 100% of options vest)
11/04/2035Expiration Date of Stock Option

Keywords

Atai Beckley N.V., ATAI, Scott Braunstein, stock option, insider transaction, Form 4, beneficial ownership, director compensation, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.